Foundayo™ (orforglipron) is an FDA-approved oral weight loss medication from Eli Lilly. It’s a glucagon-like peptide-1 (GLP-1) receptor agonist — the same class of medication as Wegovy™ and Zepbound™ — delivered as a once-daily pill instead of a weekly injection.

Foundayo™ works by reducing hunger signals in the brain, increasing feelings of fullness after eating, and slowing gastric emptying. Unlike other oral options, Foundayo™ can be taken any time of day, with or without food — no fasting or water timing required.

Coverage depends on your insurance plan and whether Foundayo™ is prescribed for an FDA-approved use. Ivím Health offers a free initial consultation to help you navigate insurance or explore self-pay options.

Foundayo™ is FDA approved for some adults with obesity, or adults who are overweight with at least one weight-related medical condition. You may be prescribed Foundayo™ online by an Ivím Health provider as part of your individualized weight management program.

Yes. The recommended protocol is to wait one week after your last injection, then begin Foundayo™ at the starting dose. Your Ivím provider will guide you through the transition and monitor how your body responds.

Choosing a GLP-1 like Foundayo™ depends on your individual health, lifestyle, medication preferences, and insurance coverage. Your Ivím provider can help determine which GLP-1 best supports your weight loss goals — whether that’s an oral daily pill, a weekly injection, or a combination approach over time.